Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program.
diabetes mellitus
lipids
lipoproteins
prediabetic state
type 2
Journal
BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
19
10
2020
revised:
18
02
2021
accepted:
25
02
2021
entrez:
1
4
2021
pubmed:
2
4
2021
medline:
22
6
2021
Statut:
ppublish
Résumé
Although various lipid and non-lipid analytes measured by nuclear magnetic resonance (NMR) spectroscopy have been associated with type 2 diabetes, a structured comparison of the ability of NMR-derived biomarkers and standard lipids to predict individual diabetes risk has not been undertaken in larger studies nor among individuals at high risk of diabetes. Cumulative discriminative utilities of various groups of biomarkers including NMR lipoproteins, related non-lipid biomarkers, standard lipids, and demographic and glycemic traits were compared for short-term (3.2 years) and long-term (15 years) diabetes development in the Diabetes Prevention Program, a multiethnic, placebo-controlled, randomized controlled trial of individuals with pre-diabetes in the USA (N=2590). Logistic regression, Cox proportional hazards model and six different hyperparameter-tuned machine learning algorithms were compared. The Matthews Correlation Coefficient (MCC) was used as the primary measure of discriminative utility. Models with baseline NMR analytes and their changes did not improve the discriminative utility of simpler models including standard lipids or demographic and glycemic traits. Across all algorithms, models with baseline 2-hour glucose performed the best (max MCC=0.36). Sophisticated machine learning algorithms performed similarly to logistic regression in this study. NMR lipoproteins and related non-lipid biomarkers were associated but did not augment discrimination of diabetes risk beyond traditional diabetes risk factors except for 2-hour glucose. Machine learning algorithms provided no meaningful improvement for discrimination compared with logistic regression, which suggests a lack of influential latent interactions among the analytes assessed in this study. Diabetes Prevention Program: NCT00004992; Diabetes Prevention Program Outcomes Study: NCT00038727.
Identifiants
pubmed: 33789908
pii: 9/1/e001953
doi: 10.1136/bmjdrc-2020-001953
pmc: PMC8016090
pii:
doi:
Substances chimiques
Lipids
0
Lipoproteins
0
Banques de données
ClinicalTrials.gov
['NCT00038727', 'NCT00004992']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDDK NIH HHS
ID : U01 DK048412
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048375
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048434
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048413
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048339
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048468
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048387
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048404
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048437
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048407
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048397
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048381
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048514
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048485
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048411
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048443
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048380
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048400
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048489
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048349
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Metabolites. 2019 May 17;9(5):
pubmed: 31108909
JAMA. 2019 Aug 8;:
pubmed: 31393527
Diabetes Care. 2018 Dec;41(12):2617-2624
pubmed: 30327364
Diabetologia. 2007 Jun;50(6):1304-14
pubmed: 17437081
Diabetes. 2010 May;59(5):1153-60
pubmed: 20185808
Pharmacol Ther. 2014 Jul;143(1):12-23
pubmed: 24509229
Diabetes Care. 2002 Dec;25(12):2165-71
pubmed: 12453955
Circulation. 2005 Jun 28;111(25):3465-72
pubmed: 15983261
Diabetes Res Clin Pract. 2020 Dec;170:108497
pubmed: 33068662
Circulation. 2009 Feb 24;119(7):931-9
pubmed: 19204302
Diabetes Care. 2004 Jun;27(6):1496-504
pubmed: 15161808
J Transl Med. 2017 Oct 27;15(1):219
pubmed: 29078787
Diabetes Care. 2019 Apr;42(4):601-608
pubmed: 30877090
Diabetologia. 1993 Jun;36(6):553-9
pubmed: 8335178
BMJ. 2011 Nov 28;343:d7163
pubmed: 22123912
Diabetes Care. 2000 Nov;23(11):1619-29
pubmed: 11092283
JAMA Cardiol. 2016 May 1;1(2):136-45
pubmed: 27347563
Lipids Health Dis. 2016 Apr 04;15:67
pubmed: 27044508
Scand J Clin Lab Invest Suppl. 2010;242:53-8
pubmed: 20515278
J Clin Med. 2018 Dec 04;7(12):
pubmed: 30518023
BMJ. 2019 May 29;365:l2154
pubmed: 31142454
Diabetologia. 2021 Feb;64(2):385-396
pubmed: 33159534
JAMA. 1990 Jun 6;263(21):2893-8
pubmed: 2338751
J Intern Med. 2012 Dec;272(6):562-72
pubmed: 22650159
Am J Epidemiol. 1990 Mar;131(3):443-53
pubmed: 2301354
Diabetes. 2003 Feb;52(2):453-62
pubmed: 12540621
Diabetes Care. 2014 Aug;37(8):2351-8
pubmed: 24804699
Diabetes Care. 2020 Feb;43(2):366-373
pubmed: 31818810
PLoS One. 2017 Apr 4;12(4):e0174944
pubmed: 28376093
J Clin Endocrinol Metab. 2013 Oct;98(10):3989-98
pubmed: 23979954
Am J Epidemiol. 2000 Jan 15;151(2):190-8
pubmed: 10645822
J Clin Lipidol. 2017 Sep - Oct;11(5):1257-1267.e2
pubmed: 28733174
Lancet Diabetes Endocrinol. 2019 Apr;7(4):267-277
pubmed: 30803929
Circ Cardiovasc Genet. 2016 Dec;9(6):495-503
pubmed: 27784733
Diabetes Care. 2019 Nov;42(11):2117-2126
pubmed: 31455687
Diabetes Care. 2016 May;39(5):833-46
pubmed: 27208380
Metabolism. 2018 Jan;78:1-12
pubmed: 28941595
BioData Min. 2017 Dec 8;10:35
pubmed: 29234465
Nature. 2015 Apr 30;520(7549):609-11
pubmed: 25925459
JAMA. 2020 Feb 18;323(7):627-635
pubmed: 32068817
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
Diabetes Res Clin Pract. 2009 Jan;83(1):132-9
pubmed: 19091436
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13892-7
pubmed: 26504198
J Clin Invest. 2011 Apr;121(4):1402-11
pubmed: 21403394
Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75
pubmed: 26377054
Lancet Digit Health. 2019 Jun;1(2):e78-e89
pubmed: 33323232
Circulation. 1995 Oct 1;92(7):1770-8
pubmed: 7671360